Vinay K. Rathi
Economics, Econometrics and Finance · The Ohio State University
Publications
161
Citations
1,711
Est. group size
~3
Recurring co-author estimate
Active years
18
Publishing since 2009
Vinay K. Rathi studies the economics and policy of healthcare, focusing on how new medical technologies, drugs, and devices are regulated, priced, and paid for by insurers like Medicare and Medicaid. Much of the recent work examines otolaryngology (ear, nose, and throat) treatments, FDA approval pathways, and hospital pricing practices, using publicly available claims and regulatory data to evaluate policy reforms. This research is aimed at informing how healthcare payment systems and regulatory programs affect patient access and costs.
Publication output grew from about 9 per year in 2017 to a peak near 23 in 2020, and has remained fairly steady at roughly 14-19 papers per year through 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Automatic Medicare Coverage for New Medical Technologies — Here We Go Again
New England Journal of Medicine · 2026
- Medicaid Coverage and Utilization for Novel Therapies for Chronic Rhinosinusitis With Nasal Polyposis
International Forum of Allergy & Rhinology · 2026
- Small Business Grants Awarded by the National Institutes of Health for Rhinologic Diseases, 1985–2024
International Forum of Allergy & Rhinology · 2026
- Price Transparency Compliance Among Hospitals Caring for Disadvantaged Populations
JAMA Network Open · 2026
- Reforming Medicare payment for skin substitutes—ripping off the bandage
Health Affairs Scholar · 2026
- FDA Authorization of Therapeutic Devices Under the Breakthrough Devices Program
JAMA Internal Medicine · 2025
- Expanding Prior Authorization in Traditional Medicare—The WISeR Model
JAMA · 2025
- Nonconcurrent Control Use in FDA Approval of High-Risk Medical Devices
JAMA Network Open · 2025
- Olfactory Cleft Opacification Improves With Intranasal Steroid Treatment and Is Correlated With Objective and Patient‐Reported Olfactory Outcomes
International Forum of Allergy & Rhinology · 2025
- Spending and Utilization for Chronic Rhinosinusitis With Nasal Polyps Therapies Among Commercially Insured Beneficiaries
The Laryngoscope · 2025
- Gene Therapy for Hearing Loss—Will the Price Be Right?
JAMA Otolaryngology–Head & Neck Surgery · 2025
- Differences in Negotiated Facility Fees for Otolaryngology Procedures at Ambulatory Surgery Centers and Hospitals
OTO Open · 2025
- Financial Impact of Medicare Payment Reform for E/M Visits on Compensation for Otolaryngologic Procedures in 2023
Otolaryngology · 2025
- WAYPOINT: Are we there yet for patients with nasal polyposis?
Med · 2025
- Hospital Acquisition Costs for Breakthrough-Designated Devices Awarded Supplemental Medicare Reimbursement
JAMA Health Forum · 2025
- Otolaryngology×30
- JAMA Otolaryngology–Head & Neck Surgery×21
- International Forum of Allergy & Rhinology×18
- The Laryngoscope×12
- JAMA Internal Medicine×7
- Seth Freedman
Economics, Econometrics and Finance · Indiana University
- Wendy Xu
Economics, Econometrics and Finance · The Ohio State University
- Simon F. Haeder
Economics, Econometrics and Finance · The Ohio State University
- Sheldon M. Retchin
Economics, Econometrics and Finance · The Ohio State University
- Paula H. Song
Economics, Econometrics and Finance · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile